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Heterobimetallic ruthenium–zinc complexes
with bulky N-heterocyclic carbenes: syntheses,
structures and reactivity†
Maialen Espinal-Viguri, Victor Varela-Izquierdo, Fedor M. Miloserdov,
Ian M. Riddlestone, Mary F. Mahon* and Michael K. Whittlesey *
The ruthenium–zinc heterobimetallic complexes, [Ru(IPr)2(CO)ZnMe][BAr
F
4] (7), [Ru(IBiox6)2(CO)(THF)
ZnMe][BArF4] (12) and [Ru(IMes)’(PPh3)(CO)ZnMe] (15), have been prepared by reaction of ZnMe2 with the
ruthenium N-heterocyclic carbene complexes [Ru(IPr)2(CO)H][BAr
F
4] (1), [Ru(IBiox6)2(CO)(THF)H][BAr
F
4]
(11) and [Ru(IMes)(PPh3)(CO)HCl] respectively. 7 shows clean reactivity towards H2, yielding [Ru(IPr)2(CO)
(η2-H2)(H)2ZnMe][BArF4] (8), which undergoes loss of the coordinated dihydrogen ligand upon application
of vacuum to form [Ru(IPr)2(CO)(H)2ZnMe][BAr
F
4] (9). In contrast, addition of H2 to 12 gave only a mixture
of products. The tetramethyl IBiox complex [Ru(IBioxMe4)2(CO)(THF)H][BAr
F
4] (14) failed to give any isol-
able Ru–Zn containing species upon reaction with ZnMe2. The cyclometallated NHC complex [Ru(IMes)’
(PPh3)(CO)ZnMe] (15) added H2 across the Ru–Zn bond both in solution and in the solid-state to afford
[Ru(IMes)’(PPh3)(CO)(H)2ZnMe] (17), with retention of the cyclometallation.
Introduction
Heterobimetallic complexes featuring a transition metal (TM)
in partnership with a Lewis acidic (LA), typically main group
element, have been the focus of considerable interest1 because
of their potential to bring about the cooperative activation of
E–H (E = H, N, Si etc.) bonds.2 The most commonly found het-
erobimetallic complexes feature a late transition metal (groups
8–10) and an element from group 13 (particularly B and Al)
and, in many cases, are readily prepared by salt elimination
reaction of a TM anion with a halide of the LA.3 While this
approach is very flexible in that there are many possible TM
and LA fragments that can be combined in this way, one (if
not both) of the partners is typically left coordinatively satu-
rated, reducing the subsequent reactivity for bond activation
processes. An alternative approach which has been employed,
although less frequently, is an alkane elimination pathway via
the reaction of a TM hydride precursor with a LA hydrocarbyl
reagent.4 This synthetic approach does come with potential
issues (e.g. the use of highly pyrophoric group 13 trialkyls, cost
of Ga/InMe3 etc.), but does allow access to heterobimetallic
complexes with unsaturation at both centres, thereby opening
up an opportunity to probe true TM-LA cooperativity.
Very recently, we reported that addition of GaMe3, InMe3
and ZnEt2 to the bulky N-heterocyclic carbene (NHC) stabilised
cationic ruthenium hydride complex [Ru(IPr)2(CO)H][BAr
F
4] (1;
IPr = 1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene; BArF4 =
[B{C6H3(3,5-CF3)2}4]
−)5 resulted in alkane elimination and for-
mation of the Ru–Ga, Ru–In and Ru–Zn complexes 2–4 shown
in Scheme 1.6 Of most relevance to this current paper was the
ruthenium–zinc complex [Ru(IPr)2(CO)ZnEt][BAr
F
4] (4) which,
upon treatment with H2, both coordinated dihydrogen at Ru and
added H2 across the Ru–Zn bond to give [Ru(IPr)2(CO)(η2-H2)
(H)2ZnEt][BAr
F
4] (5). Dissociation of the dihydrogen ligand from
this highly fluxional species took place upon heating under
vacuum to give the agostically stabilised dihydride complex,
[Ru(IPr)2(CO)(H)2ZnEt][BAr
F
4] (6, Scheme 1).
7,8
Structural analysis showed that 4 (as well as 1) was also
agostically stabilised, in this case through a bifurcated η3-H2C
ξ-agostic interaction involving an iPr substituent of the IPr
ligand. Thus, while 1 and 4 appear at first sight to be rare
examples of isolable, four-coordinate Ru(II) complexes, the
bifurcated agostic interactions impart formally 18-electron
configurations. The participation of the bulky IPr ligand in
forming agostic interactions seems to play a role in allowing 1,
4 and 6 to be isolated and structurally characterised, given that
the less sterically crowded analogue [Ru(IMes)2(CO)H]
+ (IMes =
1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene) is found only
as an oil.9
†Electronic supplementary information (ESI) available: CCDC 1882150–1882159.
For ESI and crystallographic data in CIF or other electronic format see DOI:
10.1039/c8dt05023f
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Herein, we describe efforts to elaborate on the chemistry of
1 and 4–6 through studies in which (i) the reactivity of 1
towards other ZnR2 reagents (R = Me, Ph) is probed and (ii)
analogues containing the bulky oxazoline-derived IBiox class
of NHC ligands are investigated. We also show that the for-
mation of coordinatively unsaturated and reactive (NHC)Ru–Zn
complexes is not limited to just cationic Ru–H precursors.10
Results and discussion
Reactivity of 1 towards ZnR2 reagents
The methyl zinc analogue of 4, [Ru(IPr)2(CO)ZnMe][BAr
F
4] (7),
was prepared by subjecting a C6H5F solution of 1 to a slight
excess of a toluene solution of ZnMe2. 7 was isolated as a dark
red solid in good yield (73%) and exhibited diagnostic low fre-
quency 1H (δ – 0.86) and 13C (δ – 0.7) NMR resonances for the
Zn–Me group, along with high frequency 13C signals (δ 200.6
and 188.0) arising from the presence of the carbenic and car-
bonyl carbons respectively. The structure of 7 was confirmed
by X-ray crystallography (Fig. 1), which revealed a Ru–Zn dis-
tance of 2.3997(8) Å, comparable to that in 4 (2.4069(7) Å).
There was no reaction between 1 and ZnPh2 (even upon
heating to 70 °C) presumably due to the unfavourable combi-
nation of bulky substituents on the NHC and Zn.
Upon exposure of a fluorobenzene solution of 7 to 1 atm
H2, an instantaneous change in colour from red-orange to col-
ourless was observed, resulting from the formation of the
dihydrogen dihydride complex, [Ru(IPr)2(CO)(η2-H2)(H)2ZnMe]
[BArF4] (8, Scheme 2).
11 This showed less fluxional behavior
than the ZnEt analogue 5, exhibiting three low frequency
hydride signals (δ −5.15, −7.83 and −12.16 in a 2 : 1 : 1 ratio) at
room temperature compared to just two resonances for 5
(δ −5.33 and −12.13 in a 3 : 1 ratio). Cooling a THF solution of
8 to 238 K led to sharpening of the two lower frequency reso-
nances, whereas that at ca. −5 ppm remained broader than the
others even down to 218 K. Based upon the comparable
chemical shifts and assignments in 5, the three signals were
Scheme 1 Summary of the reactivity of [Ru(IPr)2(CO)H][BAr
F
4] (1) with ZnEt2 and MMe3 (M = Ga, In).
Fig. 1 Molecular structure of the cation in [Ru(IPr)2(CO)ZnMe][BAr
F
4]
(7). Ellipsoids are shown at 30% probability. All hydrogen atoms (with the
exception of those attached to C55) removed for clarity. Selected bond
lengths (Å) and angles (°): Ru(1)–Zn(1) 2.3997(8), Ru(1)–C(1) 2.123(5),
Ru(1)–C(29) 2.108(5), Ru(1)⋯C(55) 2.462(6), Ru(1)–C(56) 1.837(6), C(1)–
Ru(1)–C(29) 175.4(2), C(56)–Ru(1)–Zn(1) 77.1(2).
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assigned to Ru(η2-H2), Ru–H–Zn trans to CO and Ru–H–Zn
trans to η2-H2 in order of decreasing frequency.
The η2-H2 ligand in 8 could be removed simply by the appli-
cation of vacuum to a solid sample of the compound
(cf. vacuum and heat for 5, Scheme 1). The resulting product,
[Ru(IPr)2(CO)(H)2ZnMe][BAr
F
4] (9), was identified by the
appearance of a low frequency (δ −25.77) doublet (2JHH =
7.7 Hz) resonance for Ru–H–Zn trans to the agostic Ru⋯H2C
the IPr ligand (vide infra), together with a higher frequency
doublet (δ −4.19, 2JHH = 7.7 Hz) arising from the Ru–H–Zn
hydride trans to CO.
The Ru–Zn complexes 8 and 9 were characterised crystallogra-
phically (Fig. 2). As anticipated, a comparison of these two com-
plexes to their ZnEt analogues 5 and 6 (Scheme 3) shows the
same patterns i.e. elongation of the Ru⋯Zn distance relative to 4
and 7, less asymmetry of the Ru–H–Zn distances for H trans to
CO and greater association with Ru for H trans to either an
agostic interaction (6 and 9) or a dihydrogen ligand (5 and 8).
Scheme 2 Synthesis and reactivity of [Ru(IPr)2(CO)ZnMe][BAr
F
4] (7).
Fig. 2 Molecular structures of the cations in (left) [Ru(IPr)2(CO)(η2-H2)(H)2ZnMe][BArF4] (8) and [Ru(IPr)2(CO)(H)2ZnMe][BArF4] (right) (9). Ellipsoids
are shown at 30% probability with all hydrogen atoms (except hydrides, those agostically bonded and the tentatively assigned dihydrogen ligand)
removed for clarity.
Scheme 3 Summary of key distances in [Ru(IPr)2(CO)(H)2ZnR][BAr
F
4]
and [Ru(IPr)2(CO)(η2-H2)(H)2ZnR][BArF4] (R = Et, Me).
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Synthesis and reactivity of Ru(IBiox) complexes
Given the success of IPr in allowing access to isolable
[Ru(NHC)2(CO)H]
+ and [Ru(NHC)2(CO)ZnR]
+ species, we
turned our attention to the IBiox class of NHCs introduced by
Glorius,12 on the basis that they are also known to be sterically
demanding and flexibly restricted. Moreover, in spite of their
use for the preparation of low-coordinate Rh and Ir com-
plexes,13 we were aware of just a single example of a Ru-IBiox
complex at the outset of our work.14
Employing previous methodology,15 the bis-carbene com-
plexes [Ru(IBiox6)2(CO)HCl] (10; for structure of IBiox6, see
Scheme 4) and [Ru(IBioxMe4)2(CO)HCl] (13; for structure of
IBioxMe4, see Scheme 5) were isolated in ca. 50–70% yield
after heating [Ru(AsPh3)3(CO)H2] with 2.5 equivalents of the
free carbenes, followed by addition of dichloromethane. The
1H NMR spectra of these 16-electron species displayed a low
frequency hydride resonance (10: δ −24.75; 13: δ −25.14)
characteristic of [Ru(NHC)2(CO)HCl] complexes.
15,16 Addition
of NaBArF4 led to abstraction of the chloride ligand to give
[Ru(IBiox6)2(CO)(THF)H][BAr
F
4] (11, Scheme 4) and
[Ru(IBioxMe4)2(CO)(THF)H][BAr
F
4] (14, Scheme 5) respectively.
The X-ray structures of neither 11 nor 14 (Fig. 3) showed any
agostic interactions to the substituents on the IBiox ligands
(e.g. shortest C–H⋯Ru in 11 is 3.182 Å).13a,c In order to relieve
the electron-deficiency of the Ru(II) centres, a THF ligand
resides in the metal coordination sphere of each complex trans
to CO.17
The X-ray crystal structure of 10 and 13, along with those of
the cations in 11 and 14, are shown in Fig. 3. A listing of metri-
cal data for the compounds is given in Table 1. As expected, all
four compounds exhibited square pyramidal geometries with
the hydride ligand in an apical position. Analysis of the NHC
tilting angle ΘNHC (Ru–CNHC–centroidNHC)
18 revealed angles of
>170° in all cases, showing that, despite the coordinative un-
saturation at ruthenium, the IBiox ligands remain free of any
structural distortions akin to those seen in some [M(IBiox)3]
+
(M = Rh, Ir) species.13c
Efforts to generate new Ru–Zn containing complexes
through reaction of 11 and 14 with ZnMe2 was successful only
in the case of the former,19 which generated [Ru(IBiox6)2(CO)
(THF)ZnMe][BArF4] (12, Fig. 4 and Scheme 4). A comparison
between the structures of 4 and 12 yield some superficial simi-
larities and some interesting differences. Both structures
contain two trans NHC ligands and coordination bonds in the
equatorial plane of which two are common, namely, one to a
zinc centre and one to a CO ligand. In 4, the remaining site is
occupied by a bifurcated agostic interaction, while in 12, there
is coordination of a THF molecule. In gross terms, the struc-
tures of both cations overlay reasonably well, but the biggest
significant difference between them lies in the relative orien-
tations of the NHC ligands. In 4, the angle between the mean
planes based on the 5-membered NHC rings is relatively stag-
gered at 102°, while the comparable angle in 12 (32°) reflects a
more eclipsed carbene conformation. The arising steric ramifi-
cations are that the CNHC–Ru–CNHC angle of 177.32(19) Å in 4
Scheme 4 Synthesis and reactivity of Ru(IBiox6) complexes.
Scheme 5 Synthesis and reactivity of Ru(IBioxMe4) complexes.
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is noticeably more linear than the 170.96(10)° angle observed in
12. It is possible that the significantly shorter Ru–Zn distance of
2.3819(4) Å in 12 (cf. 2.4069(7) Å in 4) may reflect the less encum-
bered access of the zinc ligand, towards the ruthenium centre,
via the opposite face of the cation to the NHC ligand fold.
Upon exposure to either 1 or 5 atm H2, NMR spectra of
fluorobenzene solutions of 12 exhibited signals for free IBiox6
as well as the salt [IBiox6·H][BArF4]. Any products of initial
reaction with H2 therefore appear to be of only limited
stability.
Ru–Zn bond formation from a neutral Ru–H precursor
The premise behind the initial synthesis of 1 was that addition
of ZnR2 to an electrophilic ruthenium hydride complex would
Fig. 3 Molecular structures of [Ru(IBiox6)2(CO)HCl] (10, top left), [Ru(IBioxMe4)2(CO)HCl] (13, bottom left) and the cations in [Ru(IBiox6)2(CO)(THF)
H][BArF4] (11, top right) and [Ru(IBioxMe4)2(CO)(THF)H][BAr
F
4] (14, bottom right). In all cases, ellipsoids are represented at 30% probability. In 10,
solvent hydrogen atoms and disorder have been omitted for clarity. Symmetry operation: i1 − x, y, 12 − z. In 11, hydrogen atoms, with the exception of
the hydride ligand, are omitted for clarity. Only one disordered component of the hydride ligand and of C22 is illustrated. In 13, disorder has been
omitted for clarity. Symmetry operation: i1 − x, 1 − y, 1 − z. In 14, disorder was rampant and only one component is illustrated, for clarity.
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result in the facile elimination of an alkane and formation of a
new Ru–Zn containing species. In an effort to test whether a
cationic (NHC)Ru hydride precursor was necessary, we exam-
ined the reaction of the neutral precursor [Ru(IMes)(PPh3)(CO)
HCl] with ZnMe2. In the presence of 5 equiv. ZnMe2, a rapid
reaction ensued to form the cyclometallated complex
[Ru(IMes)′(PPh3)(CO)ZnMe] (15, Scheme 6) as determined by
1H and 31P{1H} NMR spectroscopy. The formation of 15 was
accompanied by small amounts of a second product (assigned
tentatively as the non-metallated ruthenium chloride complex,
[Ru(IMes)(PPh3)(CO)(ZnMe)Cl] (16; see ESI†)), the concen-
tration of which correlated with the rate of addition of ZnMe2.
15 was itself present as major (15a) and minor (15b) forms in
solution. As a result, the Ru–CH2 group arising from C–H acti-
vation of the IMes ligand gave rise to two sets of diastereotopic
signals in the proton NMR spectrum; in THF-d8, 15a showed a
broad triplet (2JHH =
3JHP = 5.6 Hz) at δ 2.61 and a doublet of
doublets (3JHP = 11.6 Hz,
2JHH = 6.7 Hz) at δ 0.98 (each of integral
1, which both correlated (1H–13C HSQC) to a methylene carbon
resonance at δ 31), while 15b displayed a multiplet at δ 1.52 and
a doublet of doublets (3JHP = 14.4 Hz,
2JHH = 8.6 Hz) at δ 1.40;
both resonances correlated to a 13C NMR signal at δ 32.20
The similarity of chemical shifts and J values for both
species (e.g. each exhibited a high frequency resonance for the
carbenic carbon with a 2JCP value of >80 Hz, indicative of a
trans IMes-Ru-PPh3 geometry) suggested that they were most
likely conformers. There was a slight solvent dependence on
the solution ratio of 15a : 15b (88 : 12 and 82 : 18 in C6D6 and
THF-d8 respectively). The two species were shown to be in
exchange in THF-d8 by EXSY, although NOESY measurements
failed to divulge any information as to the spatial difference
between 15a and 15b. We were unable to establish any difference
Table 1 Selected bond lengths (Å) and angles (°) in Ru(IBiox) complexes 10–14
10 13 11 (X = H) 14 (X = H) 12 (X = ZnMe)
Ru–CIBiox 2.122(4) 2.086(3) 2.112(2), 2.116(3) 2.093(3), 2.098(3) 2.120(3), 2.127(3)
Ru–CO 1.782(19) 1.825(11) 1.797(4) 1.795(4) 1.818(3)
Ru–Cl 2.375(4) 2.405(3) — — —
Ru–O — — 2.168(2) 2.197(2) —
Ru–Zn — — — — 2.3819(4)
Ru–CIBiox–IBiox centroid
18 175.87 176.96 174.07, 174.01 N/A due to disorder 170.84, 171.13
Cl–Ru–CO 170.0(8) 179.2(5) — — —
O–Ru–CO — — 178.89(17) 177.99(13) 154.59(10)
Zn–Ru–CO — — — — 134.11(6)
Fig. 4 Molecular structure of the cation in [Ru(IBiox6)2(CO)(THF)
ZnMe][BArF4] (12). Ellipsoids are shown at 30% probability. Only one
component arising from the disordered carbons (C37 and C38) in the
THF ligand is illustrated.
Scheme 6 Formation of [Ru(IMes)’(PPh3)(CO)ZnMe] (15) and [Ru(IMes)’(PPh3)(CO)(H)2ZnMe] (17).
Dalton Transactions Paper
This journal is © The Royal Society of Chemistry 2019 Dalton Trans., 2019, 48, 4176–4189 | 4181
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
9 
Fe
br
ua
ry
 2
01
9.
 D
ow
nl
oa
de
d 
on
 2
/2
6/
20
20
 9
:1
9:
15
 A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
crystallographically as measurements of a number of different
single crystals only ever afforded the same structure as shown in
Fig. 5.
Upon addition of 1 atm H2 to a deep red-orange C6D6 solu-
tion of 15, an instant colour change to very pale ensued from
formation of [Ru(IMes)′(PPh3)(CO)(H)2ZnMe] (17). The
1H
NMR spectrum showed the presence of two doublet hydride
resonances at δ −6.77 (2JHP = 14.9 Hz) and δ −9.19 (2JHP = 5.0
Hz), alongside a higher frequency doublet at δ 3.22 and
doublet of doublets at δ 1.83, consistent with addition of H2
across the Ru–Zn bond rather than reversal of the IMes cyclo-
metallation. This irreversibility contrasts with what we observed
previously in the case of the related cyclometallated hydride
derivative [Ru(IMes)′(PPh3)2(CO)H], which reacted with H2 to
form [Ru(IMes)(PPh3)2(CO)H2].
20a Equally surprisingly, monitor-
ing of the reaction with H2 in the solid-state by IR spectroscopy
showed complete depletion of νCO for 15 at 1860 cm
−1 and
appearance of a new carbonyl absorption band at 1941 cm−1 for
17 upon stirring a ground up microcrystalline sample of the
former under 1 atm H2 for 2 days at room temperature.
The X-ray crystal structures of 15 and 17 (Fig. 5) show
clearly the transformation of 5-coordinate 15 to six-coordinate
17 upon reaction with H2. As anticipated (vide supra), elonga-
tion of the Ru–Zn distance from 2.3677(3) Å to 2.4828(3) Å
takes place upon H2 addition. Both bridging hydrogens were
located and refined without restraints. As in 6 and 9, the
hydride trans to CO was more evenly shared between Ru and
Zn than that, which in the case of 17, lies trans to the methyl-
ene group of the activated IMes ligand. As a result of cyclo-
metallation, neither 15 nor 17 showed a strictly linear CIMes′–Ru–P
geometry (172.32(6) and 169.10(6)° respectively). 15 exhibited a
particularly noticeable distortion of the angle at the cyclo-
metallated methylene carbon (Ru(1)–C(3)–C(4) = 83.39(12)°).21
Preliminary studies to investigate the mechanism of for-
mation of 17 revealed that exposure of 17 to D2 (1 atm) resulted
in slow (1 day, room temperature) deuterium incorporation into
both Ru–H–Zn positions, but no H/D exchange at RuCH2. This
excludes exchange taking place via a reversible reductive elimin-
ation pathway involving both RuH and RuCH2.
22 The viability of
an alternative pathway through phosphine dissociation was
probed by reaction of 17 with 5 equiv. P(p-tolyl)3. Slow PPh3/P
(p-tolyl)3 was indeed observed, but the relevance of this to the
H/D exchange was complicated by the appearance of other low
frequency proton signals arising from the decomposition of
17 that can be seen in solution over 1–2 days.
Conclusions
We have reported that ZnMe2 reacts with both cationic and
neutral ruthenium hydride precursors containing bulky
N-heterocyclic carbene ligands to afford new heterobimetallic
complexes containing Ru–Zn bonds. The IPr complex
[Ru(IPr)2(CO)ZnMe][BAr
F
4] (7) proved to be similar in terms of
both structure and reactivity towards H2 to the previously
reported ZnEt derivative 4. Use of the bulky IBiox carbene
ligands met with varying levels of success; the cyclohexyl sub-
stituted derivative IBiox6 gave [Ru(IBiox6)2(CO)(THF)
ZnMe][BArF4] (12), whereas the analogous tetramethyl
IBioxMe4 derivative could not be isolated. Of particular interest
was the formation of the neutral complex [Ru(IMes)′(PPh3)(CO)
ZnMe] (15), which added H2 across the Ru–Zn bond whilst
retaining the cyclometallated NHC ligand. As noted above, this
behaviour contrasts with the reversal of cyclometallation that
is brought about upon exposure of [Ru(IMes)′(PPh3)2(CO)H] to
H2.
20a This, together with the fact that 4 reacts with HBcat to
Fig. 5 Molecular structures of (left) [Ru(IMes)’(PPh3)(CO)ZnMe] (15) and (right) [Ru(IMes)’(PPh3)(CO)(H)2ZnMe] (17). Ellipsoids are shown at 30%
probability with all hydrogen atoms (except Ru–CH2 and Ru–H) removed for clarity. Selected bond lengths (Å) and angles (°) in 15: Ru(1)–C(1)
1.857(2), Ru(1)–C(2) 2.071(2), Ru(1)–C(3) 2.224(2), Ru(1)–P(1) 2.3360(5), Ru(1)–Zn(1) 2.3677(3), C(2)–Ru(1)–P(1) 172.32(6), C(1)–Ru(1)–C(3) 169.63(9),
Ru(1)–C(3)–C(4) 83.39(12). 17: Ru(1)–C(1) 1.874(2), Ru(1)–C(12) 1.946(2), Ru(1)–C(3) 2.1971(19), Ru(1)–P(1) 2.3342(5), Ru(1)–Zn(1) 2.4828(3), C(12)–
Ru(1)–P(1) 169.10(6), C(1)–Ru(1)–C(3) 98.77(8), Ru(1)–C(3)–C(4) 108.65(13).
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bring about dehydrocoupling (and generation of 5)6b in con-
trast to 1 which reacts with HBcat with loss of H2 and for-
mation of the stable boryl complex [Ru(IPr)2(CO)Bcat][BAr
F
4],
5
provides evidence for very different reactivity between Ru–Zn
and Ru–H containing species. Indeed, efforts to probe the
reactivity of 15 towards a broader range of E–H bonds, as well
as prepare derivatives of the complex containing other metal-
lated ligands, are in progress.
Experimental
All manipulations were carried out using standard Schlenk,
high vacuum and glovebox techniques using dried and
degassed solvents. NMR spectra were recorded on Bruker
Avance 400 and 500 MHz NMR spectrometers and run either
locked in CD2Cl2 (referenced to δ 5.32 (
1H); 54.0 (13C)), CDCl3
(referenced to δ 7.26 (1H); 54.0 (13C)), THF-d8 (referenced to δ
3.58 (1H); 67.2 (13C)) or C6D6 (referenced to δ 7.15 (
1H); 128.0
(13C)), or unlocked in C6H5F (
1H NMR spectra referenced to
the centre of the downfield multiplet at δ 7.11). IR spectra were
recorded in solution (CH2Cl2, CD2Cl2, CDCl3 or THF) or in KBr
discs on a Nicolet Nexus spectrometer. Elemental analyses
were performed by Elemental Microanalysis Ltd, Okehampton,
Devon, UK. [Ru(IPr)2(CO)H][BAr
F
4] (1),
5 IBiox6,12b IBioxMe4
12b
and [Ru(IMes)(PPh3)(CO)HCl]
23 were prepared according to
the literature.
[Ru(IPr)2(CO)ZnMe][BAr
F
4] (7)
Addition of ZnMe2 (25 μL of 1.0 M in toluene, 0.025 mmol) to
a solution of 1 (40 mg, 0.023 mmol) in C6H5F (0.6 mL) resulted
in an instantaneous change in colour from yellow to deep red.
The reaction mixture was layered with hexane, which gave dark
red crystals of 7. Yield 30 mg (73%). 1H NMR: δH (500 MHz,
CD2Cl2, 298 K) 7.73 (s, 8H, [BAr
F
4]
−), 7.56 (s, 4H, [BArF4]
−), 7.51
(t, J = 7.8 Hz, 4H, Ar), 7.32 (dd, J = 7.8, 1.4 Hz, 4H, Ar), 7.27
(dd, J = 7.8 1.4 Hz, 4H, Ar), 7.03 (s, 4H, NCHvNCH), 2.42
(sept, 3JHH = 6.8 Hz, 4H, CH(CH3)2), 2.32 (sept,
3JHH = 6.8 Hz,
4H, CH(CH3)2), 1.10 (d,
3JHH = 6.8 Hz, 12H, CH(CH3)2), 1.07 (d,
3JHH = 6.8 Hz, 12H, CH(CH3)2), 1.00 (d,
3JHH = 6.8 Hz, 12H, CH
(CH3)2), 0.65 (d,
3JHH = 6.8 Hz, 12H, CH(CH3)2), −0.86 (s, 3H,
ZnCH3).
13C{1H} NMR: δC (101 MHz, CD2Cl2, 298 K, [BAr
F
4]
−
signals are omitted) 200.6 (s, RuCO), 188.0 (s, RuCNHC), 146.5
(s), 146.3 (s), 135.7 (s), 131.7 (s), 126.3 (s), 126.1 (s), 124.1 (s),
29.8 (s), 29.3 (s, CH(CH3)2), 25.9 (s), 24.7 (s), 24.2 (s), 23.7 (s,
CH(CH3)2), −0.71 (s, ZnCH3). IR (CH2Cl2, cm−1): 1919 (νCO).
Anal. calcd for C88H87BN4OF24ZnRu: C, 57.14, H, 4.74, N, 3.03.
Found: C, 56.79, H, 4.70, N, 2.78.
[Ru(IPr)2(CO)(η2-H2)(H)2ZnMe][BArF4] (8)
A J. Young’s resealable NMR tube was charged with a C6H5F
(0.6 mL) solution of 7 (35 mg, 0.020 mmol) and ZnMe2 (22 μL,
1.0 M in toluene, 0.022 mmol) added. The resulting red solu-
tion was evaporated to dryness, redissolved in C6H5F (0.3 mL),
degassed (freeze–pump–thaw × 3) and placed under 1 atm H2.
The solution was layered with H2-purged hexane to afford pale-
colourless crystals of 8. Yield 25 mg (69%). Material for
elemental analysis was prepared by slow evaporation of a
sample of 8 prepared via exposure of a CH2Cl2 solution of 7 to
H2.
1H NMR: δH (500 MHz, CD2Cl2, 298 K) 7.73 (s, 8H,
[BArF4]
−), 7.56 (s, 4H, [BArF4]
−), 7.52 (t, J = 8.0 Hz, 4H, Ar), 7.28
(d, J = 8.0 Hz, 8H, Ar), 7.09 (s, 4H, NCHvNCH), 2.19 (sept,
3JHH = 6.8 Hz, 8H, CH(CH3)2), 1.10 (d,
3JHH = 6.8 Hz, 12H, CH
(CH3)2), 1.01–0.98 (m, 36H, CH(CH3)2), −0.66 (s, 3H, ZnCH3),
−5.15 (br s, 2H, Ru(η2-H2)), −7.83 (br s, 1H, RuHZn), −12.16 (s,
1H, RuHZn). 13C{1H} NMR: δC (126 MHz, CD2Cl2, 298 K,
[BArF4]
− signals are omitted) 196.8 (s, RuCO), 179.6 (s,
RuCNHC), 146.3 (s), 145.0 (s), 137.2 (s), 131.7 (s), 126.4 (s),
126.0 (s), 125.9 (s), 29.5 (s), 29.2 (s, CH(CH3)2), 26.4 (s), 26.2
(s), 22.9 (s), 22.6 (s, CH(CH3)2), 1.38 (s, ZnCH3). IR (CD2Cl2,
cm−1): 2005 (νCO). Anal. calcd for C88H91BN4OF24ZnRu·CH2Cl2:
C, 55.13, H, 4.83, N, 2.89. Found: C, 55.6, H, 4.64, N, 2.48.
[Ru(IPr)2(CO)(H)2ZnMe][BAr
F
4] (9)
A J. Young’s resealable NMR tube was charged with a solution
of 7 (25 mg, 0.014 mmol) in C6H5F (0.6 mL), degassed (freeze–
pump–thaw × 3) and exposed to 1 atm H2. After 30 min, the
solvent was removed in vacuo and the resulting pale orange
residue left under vacuum for 3 h. This was then dissolved in
C6H5F (0.3 mL) and layered with hexane to yield orange crys-
tals of 9. Yield 13 mg (54%). 1H NMR: δH (400 MHz, CD2Cl2,
298 K) 7.72 (s, 8H, [BArF4]
−), 7.56 (s, 4H, [BArF4]
−), 7.49 (t, 3 J =
7.8 Hz, 4H, Ar), 7.30 (d, J = 7.8 Hz, 4H, Ar), 7.23 (d, J = 7.8 Hz,
4H, Ar), 7.06 (s, 4H, NCHvNCH), 2.35 (sept, 3JHH = 6.8 Hz, 4H,
CH(CH3)2), 2.19 (sept,
3JHH = 6.8 Hz, 4H, CH(CH3)2), 1.04–0.99
(m, 36H, CH(CH3)2), 0.44 (d,
3JHH = 6.8 Hz, 12H, CH(CH3)2),
−0.72 (s, 3H, ZnCH3), −4.19 (d, 2J = 7.7 Hz, 1H, RuHZn),
−25.77 (d, 2JHH = 7.7 Hz, 1H, RuHZn). 13C{1H} NMR:
δC (101 MHz, CD2Cl2, 298 K, [BAr
F
4]
− signals are omitted)
198.3 (s, RuCO), 182.2 (s, RuCNHC), 146.5 (s), 144.9 (s), 136.4
(s), 131.4 (s), 126.7 (s), 125.8 (s), 125.5 (s), 29.3 (s), 29.3 (s, CH
(CH3)2), 26.1 (s), 24.9 (s), 23.1 (s), 22.2 (s, CH(CH3)2), 15.7
(s, ZnCH3). IR (CD2Cl2, cm
−1): 2005 (νCO). Anal. calcd for
C88H89BN4OF24ZnRu: C, 57.07, H, 4.84, N, 3.03. Found: C,
57.44, H, 4.62, N, 2.90.
[Ru(IBiox6)2(CO)HCl] (10)
[Ru(AsPh3)3(CO)H2] (728 mg, 0.69 mmol) and IBiox6 (500 mg,
1.73 mmol) were dissolved in toluene (10 mL) and stirred in a
J. Young’s resealable ampoule overnight at 363 K. After
addition of 53 μL CH2Cl2, stirring was continued at 383 K for a
further 12 h. The solvent was removed under vacuum and the
product extracted into toluene (30 mL), reduced to dryness
and washed with hexane (7 mL) and EtOH (2 × 10 mL) to give
10 as a yellow powder. Yield 280 mg (54%). 1H NMR: δH
(500 MHz, CD2Cl2, 223 K) 4.74 (d, J = 8.5 Hz, 2H, CH2O), 4.59
(q, J = 8.4 Hz, 4H, CH2O), 4.51 (d, J = 8.5 Hz, 2H, CH2O),
3.20–3.14 (m, 2H, Cy), 2.67–2.61 (m, 2H, Cy), 2.50–2.37 (m, 4H,
Cy), 2.06–2.03 (m, 2H, Cy), 1.91–1.77 (m, 14H, Cy), 1.67–1.64
(m, 4H, Cy), 1.33–1.10 (m, 12H, Cy), −24.75 (s, 1H, RuH). 13C
{1H} NMR: δC (126 MHz, CD2Cl2, 223 K) 204.1 (s, RuCO), 164.9
(s, RuCNHC), 125.3 (s), 123.8 (s, NCO), 83.9 (s), 83.2 (s, OCH2),
Dalton Transactions Paper
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65.4 (s), 64.8 (s, CCy), 35.8 (s), 35.3 (s), 34.5 (s), 33.4 (s), 24.5 (s),
24.3 (s), 24.0 (s), 24.0 (s), 23.9 (s), 23.8 (s, CH2Cy). IR (THF,
cm−1): 1890 (νCO). Anal. calcd for C35H49N4O5ClRu·CH2Cl2: C,
52.27; H, 6.21; N, 6.77. Found: C, 52.45; H, 6.30; N, 6.62.
[Ru(IBiox6)2(THF)(CO)H][BAr
F
4] (11)
Na[BArF4] (426 mg, 0.48 mmol) was added to a C6H5F solution
(15 mL) of 10 (324 g, 0.44 mmol) and the suspension stirred
for 12 h. After filtration, the solution was evaporated and the
oily residue dissolved in THF (4 mL). Addition of hexane and
vigorous stirring for 15 min afforded 11 as a yellow solid.
Yield: 615 mg (85%). Crystals suitable for X-ray diffraction
were obtained by slow diffusion of hexane into a concentrated
C6H5F solution of 11 at room temperature.
1H NMR: δH
(500 MHz, THF-d8, 298 K) 7.78 (8H, [BAr
F
4]
−), 7.57 (4H,
[BArF4]
−), 4.91 (d, J = 8.7 Hz, 2H, CH2O), 4.88 (d, J = 8.7 Hz, 2H,
CH2O), 4.68 (d, J = 8.7 Hz, 4H, CH2O), 2.89–2.83 (m, 2H, Cy),
2.65–2.59 (m, 2H, Cy), 2.24–2.21 (m, 2H, Cy), 2.17–2.11 (m, 4H,
Cy), 2.01–1.99 (m, 2H, Cy), 1.96–1.87 (m, 10H, Cy), 1.82–1.80
(m, 4H, Cy), 1.57–1.22 (m, 14H, Cy), −26.11 (s, 1H, RuH).
13C{1H} NMR: δC (126 MHz, THF-d8, 298 K, [BAr
F
4]
− signals
omitted) 205.9 (s, RuCO), 161.8 (s, RuCNHC), 127.4 (s), 125.9 (s,
NCO), 84.9 (s), 83.9 (s, OCH2), 66.9 (s), 66.1 (s, CCy), 37.5 (s),
36.8 (s), 36.7 (s), 35.4 (s), 26.6 (s), 25.8 (s), 25.6 (s), 24.7 (s),
24.6 (s), 24.4 (s, CH2Cy). IR (THF, cm
−1): 1929 (νCO). Anal. calcd
for C71H69BN4O6F24Ru·C6H5F: C, 53.2; H, 4.29; N, 3.22. Found:
C, 52.82; H, 4.22; N, 2.86.
[Ru(IBiox6)2(CO)(THF)ZnMe][BAr
F
4] (12)
Addition of ZnMe2 (67 μL of 1.0 M in toluene, 0.067 mmol) to
a J. Young’s resealable NMR tube containing a C6H5F solution
(0.6 mL) of 11 (100 mg, 0.061 mmol) resulted in an instan-
taneous colour change from yellow to orange. The reaction
mixture was evaporated to dryness, redissolved in C6H5F
(0.3 mL) and layered with hexane to yield orange crystals of 12.
Yield 69 mg (66%). 1H NMR: δH (500 MHz, THF-d8, 298 K) 7.79
(8H, [BArF4]
−), 7.57 (4H, [BArF4]
−), 4.78 (br s, 8H, CH2O), 2.89
(br s, 4H, Cy), 2.71 (br s, 4H, Cy), 2.08–2.03 (m, 8H, Cy),
1.99–1.92 (m, 8H, Cy), 1.82–1.76 (m, 8H, Cy), 1.54–1.47 (m, 4H,
Cy), −0.01 (s, 1H, ZnCH3). 13C{1H} NMR: δC (126 MHz, THF-d8,
298 K, [BArF4]
− signals omitted) 209.5 (s, RuCO), 161.8 (s,
RuCNHC), 127.5 (s, NCO), 84.2 (s, OCH2), 68.4 (s, CCy), 36.4 (s),
26.6 (s), 25.4 (s), 24.7 (s), 24.5 (s, CH2Cy), −0.28 (s, ZnCH3). IR
(THF, cm−1): 1929 (νCO).
[Ru(IBioxMe4)2(CO)HCl] (13)
[Ru(AsPh3)3(CO)H2] (1.11 g, 1.06 mmol) and IBioxMe4
(552 mg, 2.65 mmol) were dissolved in toluene (10 mL) and
the solution heated in a J. Young’s resealable ampoule over-
night at 363 K. After addition of 102 μL (1.59 mmol) of CH2Cl2,
heating was continued at 393 K for a further 24 h. After that
time a solid had formed, which was isolated by cannula fil-
tration and washed with hexane (2 × 10 mL) and EtOH (10 mL)
to give 13 as a yellow powder. Yield 424 mg (69%). Yellow crys-
tals suitable for X-ray diffraction were obtained layering a
CH2Cl2 solution of the complex with hexane.
1H NMR: δH
(500 MHz, CDCl3, 298 K) 4.48 (s, 8H, CH2O), 1.95–1.65 (s, 24H,
CH3), −25.14 (s, 1H, RuH). 13C{1H} NMR: δC (126 MHz, CDCl3,
298 K) 203.2 (s, RuCO), 166.6 (s, RuCNHC), 125.4 (s), 124.5 (s,
NCO), 88.0 (s), 87.4 (s, OCH2), 61.2 (s), 60.7 (s, C(CH3)2),
27.6 (s), 27.1 (s), 26.3 (s), 26.1 (s, CH3). IR (CDCl3, cm
−1): 1895
(νCO). Anal. calcd for C23H33N4O5ClRu·0.5C6H5F: C, 49.56; H,
5.68; N, 8.89. Found: C, 48.97; H, 5.59; N, 8.51.
[Ru(IBioxMe4)2(THF)(CO)H][BAr
F
4] (14)
Na[BArF4] (168 mg, 0.19 mmol) was added to a C6H5F solution
(15 mL) of 13 (100 mg, 0.17 mmol) and the suspension stirred
overnight at room temperature. After filtration, the filtrate was
evaporated to dryness and the residue redissolved in THF
(4 mL). Addition of hexane and vigorous stirring for 15 min
afforded 14 as a brown solid. Yield 190 mg (79%). Crystals suit-
able for X-ray diffraction were obtained by slow diffusion of
hexane into a concentrated THF solution of 14 at room temp-
erature. 1H NMR: δH (400 MHz, THF-d8, 298 K) 7.80 (s, 8H,
[BArF4]
−), 7.59 (s, 4H, [BArF4]
−), 4.71–4.66 (m, 4H, OCH2),
4.61–4.57 (m, 4H, OCH2), 1.90 (s, 6H, CH3), 1.85 (s, 6H, CH3),
1.74 (s, 6H, CH3), 1.59 (s, 6H, CH3), −26.13 (s, 1H, RuH). 13C
{1H} NMR: δC (101 MHz, THF, 298 K, [BAr
F
4]
− signals omitted)
203.8 (s, RuCO), 161.1 (s, RuCNHC), 126.2 (s), 125.1 (s, NCO),
87.6 (s), 86.8 (s, OCH2), 61.7 (s), 61.0 (s, C(CH3)2), 26.0 (s), 25.8
(s), 25.3 (s), 25.3 (s, CH3). IR (THF, cm
−1): 1933 (νCO). Anal.
calcd for C55H45BF24N4O5Ru.C4H8O: C, 47.82; H, 3.6; N, 3.78.
Found: C, 47.89; H, 3.55; N, 3.14.
[Ru(IMes)′(PPh3)(CO)ZnMe] (15)
Rapid addition of ZnMe2 (1.22 mL of 1.2 M solution in
toluene, 1.46 mmol) to a J. Young’s resealable ampoule con-
taining a THF solution (10 mL) of [Ru(IMes)(PPh3)(CO)HCl]
(214 mg, 0.292 mmol) resulted in an instantaneous colour
change from yellow to dark orange. The reaction mixture was
stirred for 5 min, concentrated to ca. 1 mL and Et2O (15 mL)
added. After filtration through a short pad of Celite®, the fil-
trate was left to stand at room temperature, whereby an initial
batch of orange crystals (94 mg, 42% yield) formed. After sep-
aration by filtration, the mother liquor was concentrated (ca.
8 mL), left to stand, and a further 40 mg of crystalline product
was formed. This was shown by NMR spectroscopy to comprise
of ca. 92% 15 and ca. 8% of a second product, which we assign
as [Ru(IMes)(PPh3)(CO)(ZnMe)Cl] (16; ESI†). In solution, 15
was found to exist as a mixture of two forms, believed to be the
conformers 15a and 15b. 1H NMR of 15a: δH (400 MHz, C6D6,
298 K) 7.57–7.46 (m, 6H, PPh3), 7.06–6.94 (m, 9H, PPh3), 6.84
(s, 1H, Ar), 6.72 (s, 1H, Ar), 6.64 (s, 1H, Ar), 6.38 (d, 3JHH = 1.7
Hz, 1H, NCHvNCH), 6.21 (d, 3JHH = 1.7 Hz, 1H, NCHvNCH),
6.00 (s, 1H, Ar), 3.17 (br t, 2JHH =
3JHP = 5.9 Hz, 1H, RuCHH),
2.27 (s, 3H, CH3), 2.23 (s, 3H, CH3), 2.08 (s, 6H, CH3), 1.99 (s,
6H, CH3), 1.59 (dd,
3JHP = 11.6 Hz,
2JHH = 6.5 Hz, 1H, RuCHH),
−0.57 (s, 3H, ZnCH3). 31P{1H} NMR: δP (162 MHz, C6D6, 298 K)
52.1 (s). 13C{1H} NMR: δC (101 MHz, C6D6, 298 K) 206.7 (d,
2JCP = 11 Hz, RuCO), 196.2 (d,
2JCP = 83 Hz, RuCNHC), 139.1 (s,
Ar), 138.9 (d, JCP = 12 Hz, PPh3), 137.5 (s, Ar), 136.6 (s, Ar),
136.3 (s, Ar), 135.2 (s, Ar), 134.4 (d, JCP = 12.0 Hz, PPh3), 133.1
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(s, Ar), 131.6 (s, Ar), 130.5 (s, Ar), 130.2 (s, Ar), 129.1 (d, JCP = 1
Hz, PPh3), 128.9 (s, Ar), 128.1 (s, Ar), 125.7 (s, Ar), 122.3 (d,
4JCP
= 3 Hz, NCHvCHN), 120.3 (d, 4JCP = 3 Hz, NCHvCHN), 31.6
(d, 2JCP = 7 Hz, RuCH2), 21.3 (s, CH3), 21.1 (s, CH3), 19.0 (s,
CH3), 18.7 (s, CH3), 18.1 (s, CH3), −1.5 (d, 3JCP = 3 Hz, ZnCH3).
1H NMR: δH (500 MHz, THF-d8, 298 K) 7.47–7.13 (m, 17H, Ar +
NCHvCHN), 7.00 (s, 1H, Ar) 6.99 (s, 1H, Ar), 6.62 (s, 1H, Ar),
5.55 (s, 1H, Ar), 2.61 (br t, 2JHH =
3JHP = 5.6 Hz, 1H, RuCHH),
2.34 (s, 3H, CH3), 2.30 (s, 3H, CH3), 2.25 (s, 3H, CH3), 2.17 (s,
3H, CH3), 1.87 (s, 3H, CH3), 0.98 (dd,
3JHP = 11.6 Hz,
2JHH = 6.7
Hz, 1H, RuCHH), −1.21 (s, 3H, ZnCH3). 31P{1H} NMR: δP
(202 MHz, THF-d8, 298 K) 50.1 (s). Selected
13C{1H} NMR: δC
(126 MHz, THF-d8, 298 K) 206.4 (d,
2JCP = 11 Hz, RuCO), 195.9
(d, 2JCP = 83 Hz, RuCNHC), 31.1 (d,
2JCP = 7 Hz, RuCH2), −2.4 (d,
3JCP = 4 Hz, ZnCH3). 15b:
1H NMR: δH (500 MHz, THF-d8,
298 K) 7.73 (s, 1H, NCHvNCH), 7.47–7.13 (m, 16 H, PPh3 and
NCHvNCH), 6.95 (s, 1H, Ar), 6.92 (s, 1H, Ar), 6.46 (s, 1H, Ar),
6.03 (s, 1H, Ar), 2.28 (s, 3H, CH3), 2.26 (s, 3H, CH3), 2.16 (s,
3H, CH3), 2.12 (s, 3H, CH3), 1.86 (s, 3H, CH3), 1.52 (m, 1H,
RuCHH), 1.40 (dd, 3JHP = 14.4 Hz,
2JHH = 8.6 Hz, 1H, RuCHH),
−0.90 (s, 3H, ZnCH3). 31P{1H} NMR: δP (202 MHz, THF-d8,
298 K) 57.1 (s). Selected 13C{1H} NMR: δC (126 MHz, THF-d8,
298 K) 203.3 (d, 2JCP = 8 Hz, RuCO), 200.1 (d,
2JCP = 82 Hz,
RuCNHC), 31.7 (d,
2JCP = 9 Hz, RuCH2), −4.0 (s, ZnCH3). IR
(KBr, cm−1): 1860 (νCO). Anal. calcd for C41H41N2OPRuZn: C,
63.52, H, 5.33, N, 3.61. Found: C, 63.30, H, 5.30, N, 3.69.
[Ru(IMes)′(PPh3)(CO)(H)2ZnMe] (17)
Addition of H2 (1 atm) to a J. Young’s resealable ampoule tube
containing a Et2O solution (1 mL) of 15 (34 mg, 0.044 mmol)
resulted in an instantaneous colour change from red-orange to
colourless/pale yellow. After 30 min, the solvent was removed,
the solid washed with Et2O (3 × 0.5 mL) and the colourless
solid dried under vacuum. Yield 19 mg (55%). 1H NMR: δH
(500 MHz, C6D6, 298 K) 7.71–7.65 (m, 6H, Ar), 7.09–6.96 (m,
9H, Ar), 6.89 (d, 3JHH = 1.3 Hz, 1H, NCHvCHN), 6.77 (s, 1H,
Ar), 6.74 (s, 1H, Ar), 6.68 (s, 1H, Ar), 6.62 (s, 1H, Ar), 6.17 (d,
3JHH = 1.4 Hz, 1H, NCHvCHN), 3.22 (d,
2JHH = 9.2 Hz, 1H,
RuCHH), 2.26 (s, 3H, CH3), 2.14 (s, 3H, CH3), 2.13 (s, 3H, CH3),
2.07 (s, 6H, CH3), 1.83 (dd,
3JHP = 12.3 Hz,
2JHH = 9.6 Hz, 1H,
RuCHH), −1.29 (s, 3H, ZnCH3), −6.77 (d, 2JHP = 14.9 Hz, 1H,
RuHZn), −9.19 (d, 2JHP = 5.0 Hz, RuHZn). 31P{1H} NMR: δP
(202 MHz, C6D6, 298 K) 55.4 (s).
13C{1H} NMR: δC (126 MHz,
C6D6, 298 K) 203.0 (d,
2JCP = 14 Hz, RuCO), 194.6 (d,
2JCP = 83
Hz, RuCNHC), 156.0 (s, Ar), 139.9 (s, Ar), 138.7 (d, JCP = 38 Hz,
PPh3), 137.8 (s, Ar), 137.1 (s, Ar), 136.7 (s, Ar), 135.4 (s, Ar),
135.1(s, Ar), 134.4 (d, JCP = 11 Hz, PPh3), 130.8 (s, Ar), 130.5 (s,
Ar), 129.4 (s, PPh3), 128.8 (s, Ar), 125.2 (s, Ar), 121.8 (d,
4JCP = 2
Hz, NCHvCHN), 119.5 (d, 4JCP = 3 Hz, NCHvCHN), 21.3 (s,
CH3), 21.1 (s, CH3), 19.8 (s, CH3), 18.7 (s, CH3), 18.4 (s, CH3),
7.7 (d, 2JCP = 7 Hz, RuCH2), −5.4 (s, ZnCH3). IR (KBr, cm−1):
1941 (νCO). Efforts to record elemental analyses repeatedly gave
low %C values (e.g. Anal. calcd for C41H43N2OPRuZn: C, 63.36,
H, 5.58, N, 3.60. Found: C, 61.23, H, 5.40, N, 3.65) which we
attribute to the decomposition of the compound with time.
X-ray crystallography
Data for 7, 9, 11 and 12 were collected using an Agilent
Xcalibur diffractometer while those for 8, 10, 13, 14, 15 and 17
were obtained using an Agilent SuperNova instrument
(Table 2). All experiments were conducted at 150 K, solved
using charge-flipping algorithm implemented in Olex224 and
refined using SHELXL.25 In structures where disorder was
observed in a [BArF4] anion, C–F, F⋯F, C⋯F and ADP restraints
were applied, on merit. Otherwise, refinements were largely
straightforward. Hence, only points of merit will be detailed
hereafter. The asymmetric unit in 7 comprises one cation and
one anion. The hydrogens attached to C55 in the former were
located and refined subject to having similar C–H bond dis-
tances and to being equidistant from each other. F7, F8 and
F9 were each disordered over 2 sites in the anion. H1, H2 and
H3 in the cationic portion of compound 8 were readily located
and, after some effort, an assignment was also made for H4.
The associated Uiso values were refined freely, and that for H4
is somewhat higher than one might expect. However, this may
well reflect some movement in the ligated dihydrogen,
wherein the constituent atoms were refined subject to being
equidistant from Ru1 and at a distance of 0.75 Å from each
other (the refined H–H distance, on this basis, is 0.75(1) Å).
The bridging hydrides were refined without restraints.
Residual electron density maxima in this structure are in the
region of the anion CF3 groups, five of which merited disorder
modelling. In particular, F7–F12 were each refined over 2 posi-
tions in a 50 : 50 disorder ratio while F1–F3 exhibited 70 : 30
disorder. Moreover, the entire CF3 moieties based on C71 and
C80 were refined to take account of 70 : 30 and 55 : 45 disorder
levels, respectively.
In 9, the asymmetric unit contains one cation, one anion
and one molecule of CH2Cl2. H1 and H2 in the cation were
located a refined without restraints. The hydrogens attached to
C26 were similarly located and refined subject to being located
at a distance of 0.98 Å from C26. Fluoride disorder was mod-
elled for two of the [BArF4] CF3 moieties. In particular, F1–F3
were disordered over two sites in a 75 : 25 ratio while F13–15
were disordered over three sites in a 50 : 40 : 10 ratio. The
solvent molecule exhibited 55 : 45 disorder and C–Cl distances
were restrained to being similar in both moieties. ADP
restraints were included for fractional occupancy atoms. The
asymmetric unit in 10 equates to half of one molecule of the
complex, and half of a benzene molecule. The chloride and
carbonyl ligands within the metal complex are disordered with
each other in a 50 : 50 ratio. The hydride ligand (which is likely
to be disordered over 2 sites) could not be reliably located and,
hence, was omitted from the refinement. One cation, one
anion and two independent fluorobenzene halves constitute
the asymmetric unit in 11. The solvent moieties are proximate
to crystallographic inversion centres which serve, in each case,
to generate the remaining molecule portions. The halides in
these solvent moieties are necessarily disordered and, hence,
exhibit half site-occupancies. 75 : 25 disorder was also mod-
elled for C22 in the cation, with chemically similar distances
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Table 2 Crystal data and structure refinement details for compounds 7–15 and 17
Identification code 7 8 9 10 11
Empirical formula C88H87BF24N4ORuZn C88H91BF24N4ORuZn C89H91BCl2F24N4ORuZn C41H55ClN4O5Ru C77H74BF25N4O6Ru
Formula weight 1849.86 1853.89 1936.80 820.41 1738.28
Crystal system Orthorhombic Triclinic Triclinic Monoclinic Triclinic
Space group P212121 P1ˉ P1ˉ C2/c P1ˉ
a/Å 16.4346(4) 12.7837(2) 13.1638(4) 22.2537(14) 14.9600(4)
b/Å 21.1397(5) 17.1267(3) 17.7078(6) 13.5448(8) 15.8674(5)
c/Å 24.5462(5) 20.4172(3) 19.6253(6) 12.4203(7) 16.5741(5)
α/° 90 84.063(1) 95.885(2) 90 87.261(3)
β/° 90 88.767(1) 94.337(2) 93.810(5) 80.381(2)
γ/° 90 85.402(1) 98.208(2) 90 75.276(2)
U/Å3 8527.9(3) 4431.51(12) 4485.0(2) 3735.5(4) 3751.5(2)
Z 4 2 2 4 2
ρcalc/g cm
−3 1.441 1.389 1.434 1.459 1.539
μ/mm−1 0.559 0.538 0.593 4.463 0.327
F(000) 3784.0 1900.0 1980.0 1720.0 1772.0
Crystal size/mm3 0.528 × 0.38 × 0.378 0.317 × 0.132 × 0.103 0.577 × 0.493 × 0.41 0.324 × 0.214 × 0.167 0.56 × 0.542 × 0.434
Radiation MoKα MoKα MoKα CuKα MoKα
2θ range for data collection/° 6.668 to 54.968 5.164 to 61.016 6.794 to 54.968 10.28 to 145.568 6.87 to 54.968
Index ranges −20 ≤ h ≤ 18 −18 ≤ h ≤ 18 −17 ≤ h ≤ 17 −26 ≤ h ≤ 27 −17 ≤ h ≤ 19
−27 ≤ k ≤ 27 −24 ≤ k ≤ 24 −22 ≤ k ≤ 19 −16 ≤ k ≤ 16 −18 ≤ k ≤ 20
−31 ≤ l ≤ 31 −29 ≤ l ≤ 28 −24 ≤ l ≤ 22 −15 ≤ l ≤ 9 −21 ≤ l ≤ 21
Reflections collected 77 177 159 961 40 172 16 638 46 082
Independent reflections, Rint 19 171, 0.0429 26 703, 0.0629 19 792, 0.0362 3649, 0.0935 16 803, 0.0392
Data/restraints/parameters 19 171/67/1136 26 703/157/1267 19 792/240/1246 3649/0/249 16 803/334/1188
Goodness-of-fit on F2 1.077 1.042 1.037 1.074 1.063
Final R1, wR2, I ≥ 2σ(I) 0.0511, 0.1112 0.0503, 0.1188 0.0467, 0.1017 0.0512, 0.1314 0.0617, 0.1407
Final R1, wR2, all data 0.0680, 0.1206 0.0694, 0.1298 0.0675, 0.1136 0.0531, 0.1326 0.0813, 0.1516
Largest diff. peak/hole/e Å−3 0.83/−0.86 0.76/−1.18 0.88/−0.57 0.68/−0.64 2.80/−0.68
Flack parameter 0.017(4) — — — —
Identification code 12 13 14 15 17
Empirical formula C72H71BF24N4O6RuZn C23H32ClN4O5Ru C59H52BF24N4O6Ru C41H41N2OPRuZn C41H43N2OPRuZn
Formula weight 1721.57 581.04 1480.92 775.17 777.18
Crystal system Triclinic Monoclinic Triclinic Monoclinic Triclinic
Space group P1ˉ P21/n P1ˉ P21/c P1ˉ
a/Å 12.9608(4) 10.2772(2) 9.9024(1) 10.5880(1) 9.8428(2)
b/Å 13.1449(4) 11.4391(2) 18.4531(2) 25.6243(2) 11.4984(3)
c/Å 21.6148(7) 10.8292(2) 19.4882(3) 13.6538(1) 17.9210(3)
α/° 94.981(3) 90 112.078(1) 90 87.163(2)
β/° 91.296(3) 99.331(2) 103.002(1) 103.780(1) 81.171(2)
γ/° 97.163(3) 90 96.389(1) 90 65.917(2)
U/Å3 3637.8(2) 1256.26(4) 3138.80(7) 3597.79(5) 1829.55(7)
Z 2 2 2 4 2
ρcalc/g cm
−3 1.572 1.536 1.567 1.431 1.411
μ/mm−1 0.654 6.375 3.144 4.896 4.814
F(000) 1748.0 598.0 1494.0 1592.0 800.0
Crystal size/mm3 0.561 × 0.375 × 0.27 0.072 × 0.058 × 0.019 0.283 × 0.229 × 0.094 0.471 × 0.095 × 0.092 0.116 × 0.08 × 0.05
Radiation MoKα CuKα CuKα CuKα CuKα
2θ range for data collection/° 6.678 to 54.966 11.012 to 146.588 5.636 to 147.162 6.9 to 146.304 4.99 to 146.094
P
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in each disordered component being restrained to being
similar. The hydride was also located and is disordered in a
50 : 50 ratio. The associated metal-hydride distances were
refined subject to a 1.6 Å, Ru–H, distance restraint. Anion dis-
order was limited to the halides in five of the CF3 functional-
ities. Specifically, the fluorines attached to C46, C54, C55, C63
and C70 exhibited disorder ratios of 65 : 35, 55 : 45, 50 : 50,
75 : 25 and 75 : 25, respectively.
Some disorder modelling was necessary in both that cation
and the anion present in the asymmetric unit of compound
12. In the cation, this pertained to 55 : 45 disorder confined to
atoms C37 and C38 in the THF ligand. Chemically equivalent
distances involving the partial occupancy atoms were
restrained to being similar in the final least-squares and some
ADP restraints were also included for same. Four of the CF3
groups in the anion were seen to exhibit disorder. In particu-
lar, the fluorine atoms attached to C47, C56, C63 and C72 were
each modelled over 2 sites, in ratios of 55 : 45, 60 : 40, 55 : 45
and 75 : 25, respectively. The asymmetric unit in 13 comprises
half of a molecule, with the central ruthenium located at a
crystallographic inversion centre. This necessarily means that
the chloride and carbonyl ligands are disordered in a 50 : 50
ratio. An exemplary diffraction pattern was observed for crystal
of compound 14 where the asymmetric unit was seen to
contain one cation and one anion. There was no evident twin-
ning but, yet, the structural motif itself is riddled with dis-
order. While this was successfully modelled, it has inevitably
resulted in the addition of a large number of restraints to the
model, as both carbene ligands in the cation were seen to be
disordered in a 50 : 50 ratio. The carbene carbons are, in each
ligand, common to both components. In addition, C26 in the
THF ligand was also seen to exhibit disorder, which optimally
refined to a 60 : 40 ratio. Distance similarity restraints and ADP
restraints were added to the model for the cation, on merit, in
the final refinement cycles. In the BArF4 anion, three of the
rings were seen to be disordered in an 80 : 20 ratio. The moiety
based on C36 did not exhibit disorder to a level that could be
credibly modelled, although the CF3 group based on C42 was
treated for 70 : 30 disorder.
In 15, both H3a and H3b were located and subsequently
refined subject to each being a distance of 0.98 Å from C3. In a
similar vein, the hydrogens attached to C3 were also readily
located in 17, and each refined subject to being situated at dis-
tance of 0.95 Å from the parent atom. Finally, the bridging
hydride ligands were also located in this compound and
refined without restraints.
Crystallographic data for all compounds have been de-
posited with the Cambridge Crystallographic Data Centre as
supplementary publications CCDC 1882150 (compound 7),
1882152 (8), 1882151 (9), 1882153 (10), 1882154 (11), 1882155 (12),
1882156 (13), 1882157 (14), 1882158 (15) and 1882159 (17).†
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